细胞因子诱导的杀伤细胞的生物学特性研究

目的:探讨细胞因子诱导的杀伤细胞(CIK)的生物学特性。方法:健康人非贴壁单个核细胞用含IFN-γ、IL-1β、IL-2、CD3单抗诱导CIK细胞。以LAK细胞作为对照。流式细胞仪和免疫细胞化学染色检测细胞表型特征;乳酸脱氢酶释放法分析细胞毒活性。结果:诱导2周后,CIK细胞的增殖率达到高峰,CD3⁺细胞占95％以上;第3周细胞生长进入平台期。诱导15d时,CD3⁺CD56⁺NKT亚群占16.5％,比例在2-4周区间内无明显变化。LAK细胞增殖缓慢,显著低于同期CIK细胞增殖率(P＜0.01)。不同效:靶比例CIK细胞对肝癌细胞BeL-7402的特异性溶解率显著高于LAK细胞(P＜0.01)。免疫细胞化学染色结果显示,CIK细胞高度表达HLA-DR和CD54抗原,NKT细胞体积较CD3⁺CD56^-细胞略大,细胞表面有大量伪足。结论:CIK细胞具有高度增殖能力,其体外杀瘤活性明显优于LAK细胞。诱导14-21d,CIK细胞增殖率和CD3⁺CD56⁺阳性细胞率均达到高峰,此时期的CIK细胞适合临床应用。

The biological characteristics of cytokine - induced killer cells

AIM:To investigate the biological characteristics of cytokine-induced killer (CIK) cellsin vitro.METHODS:The non-adhere peripheral blood monoclear cells from healthy donors were induced into CIK cells in the presence of IFN-γ, IL-1β, IL-2 and anti-CD3 antibody. LAK (lymphokine activated killer) cells were prepared as a control. The cellular phenotype were detected by FCM and immunocytochemistry and the cytotoxicity was measured by LDH release assay.RESULTS:After 2 weeks of induction, the proliferation rate of CIK cells reached a peak and the proportion of CD3⁺ population was above 95%, and then the cells growth entered to plateau phase at week 3. The proportion of CD3⁺CD56⁺ NKT subset cells was 16.5% on day 15 and it had no obvious variety between 2 and 4 weeks. Correspondingly, LAK cells grew slowly and had lower proliferation rate compared with the CIK cells (P<0.01). CIK cells showed higher specific lysis rates to BeL-7402 hepatoma cells than those of LAK cells at different effector to target ratio (P<0.01). Immunocytochemical staining showed the CIK cells highly co-expressed HLA-DR and CD54 antigens. The NKT cells were slightly bigger than CD3⁺CD56^- cells and a large quantity of pseudopodia were observed on their surface.CONCLUSION:The CIK cells have higher proliferation potency and stronger cytotoxicity to lyse tumor cells than LAK cellsin vitro.Within the span of time from 14 to 21 days, the proliferation rate and the proportion of CD3⁺CD56⁺ subset of CIK cells all reach peaks. Therefore, CIK cells in this period are suitable for clinical application.